Persistence of immunity following 2-dose priming with a 10-valent pneumococcal conjugate vaccine at 6 and 10 weeks or 6 and 14 weeks of age in Nepalese toddlers

<p><strong>Background: </strong></p> The pneumococcal conjugate vaccine has had a substantial impact on invasive pneumococcal disease. Previously, we compared immunity following vaccination with the 10-valent pneumococcal conjugate vaccine (PCV10) administered at 2 slightly d...

Full description

Bibliographic Details
Main Authors:	Gurung, M, Bijukchhe, SM, Hariri, P, Voysey, M, Kandasamy, R, Thorson, S, Maskey, P, Pandit, R, Shrestha, B, Gautam, MC, Maharjan, M, Lama, L, Acharya, B, Basi, R, K C, M, O'Reilly, P, Shrestha, S, Ansari, I, Shah, GP, Kelly, S, O'Brien, KL, Goldblatt, D, Kelly, DF, Murdoch, DR, Pollard, AJ
Format:	Journal article
Language:	English
Published:	Lippincott, Williams & Wilkins 2021

Persistence of immunity following 2-dose priming with a 10-valent pneumococcal conjugate vaccine at 6 and 10 weeks or 6 and 14 weeks of age in Nepalese toddlers

Similar Items